Guest guest Posted August 2, 2003 Report Share Posted August 2, 2003 http://www.cancer-coverup.com/newsletter/print-version/prescription-drug-costs_0\ 8-2002.asp Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 10, 2010 Report Share Posted March 10, 2010 Thank you. Interesting and informative. In addition to where you purchase, I think price is influenced by production costs (biologics like Rituxan costing lots more than chemical compounds), the need for the company to recoup Research Development and Clinical testing costs, and Scale - the fewer indications (uses) and clients who can pay for it, the higher the cost must be to make up for R & D - which is about 1 billion dollars per drug. In the US it can be argued that the rising uninsured population is driving costs up for those who can still afford to pay. Karl > > According to Oncology Business Review a 6 month course of treatment for CLL of Arzerra™ (Ofatutumab) will run about $98,000. > > This is heavily front loaded as well according to an article in the December 2009 > New York Times; " About $60,000 of the cost would be incurred in the first eight weeks, when the drug (Arzerra™) is given more frequently. " > > From personal experience, the cost of Rituxan is between $18,000 -$20,000 in Canada for one cycle of treatment with FC. > > Campath-H based in figures from England for 24 doses is about $15,000 US. However, many treatment cycles use 40 doses. > > The average wholesale price (AWP) of Bendamustine is $4,320 per dose. One treatment cycle is double.($8,640). Pharma RedBook (2008) > > Bendamustine in Poland is about $200 a dose and free in Cuba, so I have been told. > > The AWP of Chlorambucil is $75 per dose, or $151 per treatment cycle. Pharma RedBook (2008) > > Fludarabine - mono therapy is about $5200 ( 6 cycles of treatment) > > CHOP - about $7,500 a treatment round in 2003 in Canada. > > Revlimid - $6195 a month - Wall Street Journal (2006) > > A few things to note: > > It really matters were you are purchasing the stuff. Every country is very different. These differences are largely predicated on different marketing set-ups, royalties, market size > and country's wealth. (whatever the market will bear) > > These drug costs are highly manipulated and sometime discounted by the drug companies. > > These are only primary drugs used in treatment and there are often a number > of other drugs used in a treatment cycle that can add considerably to the cost. > > ~chris > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.